Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
波兰语
10 Artikel pro Seite (Seite 1 / 1) Insgesamt 4 Artikel
01-14
01-14
01-13
12-28
12-25
12-23
12-18
12-04
12-02
11-19